跳至主要内容
临床试验/CTRI/2024/07/069890
CTRI/2024/07/069890尚未招募3 期

A randomised single blind placebo controlled comparative clinical study to evaluate the efficacy of Bodhi Satva Sukshma Aushadhi in the management of Attention Deficit Hyperactivity Disorder in children. - NI

D.Y.Patil Deemed to be University, School of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children aged between 5-12 years of age
  • 2. Children having signs and clinically diagnosed for Attention Deficit Hyperactivity Disorder ADHD as per DSM-5 Criteria.

排除标准

  • 1. Children not fulfilling the DSM-5 Criteria for diagnosis of Attention Deficit Hyperactivity Disorder ADHD.
  • 2. Known case of Cerebral palsy, mental retardation and epilepsy.
  • 3. Known case of hearing deficit.
  • 4. Children with obvious congenital anomalies like Cleft Palate, Coronary Heart Disease.
  • 5. Known case of major systemic disorders and metabolic disorders.

研究者

发起方
D.Y.Patil Deemed to be University, School of Ayurveda

相似试验